Finance

Lists
Outlook: 78.1% bullish·3.1% bearish
Go to analysis
AMGN34:BVMF
Amgen Inc. BDR
၉၃.၁၆ R$
+၁.၃၈%
(+၁.၂၇) 1D
နို ၁၀, GMT-၃ ၁၇:၄၅:၁၆  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for AMGN34...
Open
၉၂.၄၆ R$
High
၉၃.၁၆ R$
Low
၉၂.၃၈ R$
Mkt. cap
ဋေ ၂.၅၂ သ
Avg. vol.
၃၁၈.၀၀
Volume
၆.၀၀
52-wk high
၉၄.၇၂ R$
52-wk low
၄၇.၇၆ R$
Shares outstanding
၅၄.၀၉ ကုဋေ
No. of employees
၃ သောင်း
Open
၉၂.၄၆ R$
High
၉၃.၁၆ R$
Low
၉၂.၃၈ R$
Mkt. cap
ဋေ ၂.၅၂ သ
Avg. vol.
၃၁၈.၀၀
Volume
၆.၀၀
52-wk high
၉၄.၇၂ R$
52-wk low
၄၇.၇၆ R$
Shares outstanding
၅၄.၀၉ ကုဋေ
No. of employees
၃ သောင်း
News stories
From web sources and news partners
CNBC
CNBC
·
ပြီးခဲ့သည့် ၃ နာရီ
Explosive Options' Bob Lang on why he likes Amgen
Investing.com Canada
Investing.com Canada
·
ပြီးခဲ့သည့် ၂၁ နာရီ
Form 4 Amgen Inc: Omar Ishrak (Director) For: 6 November By Investing.com
MarketWatch
MarketWatch
·
ပြီးခဲ့သည့် ၁ ရက်
Amgen Inc. stock rises Monday, still underperforms market
Amgen
Amgen
·
ပြီးခဲ့သည့် ၆ ရက်
AMGEN REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics. The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody. Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection. The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc. BDR
CEORobert A. Bradway
Employees၃.၁၅ သောင်း
Founded၁၉၈၀
Headquartersသောင်စင်အုက်စ်, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth Care
Industry-
Websiteamgen.com
Last report
၂၀၂၆ နို ၃
Fiscal period
Q3 2026
၆.၄၅ US$ / ၅.၇၉ US$
+၁၁.၄၅%beat
Revenue / Est. (USD)
ဋေ ၁.၀၄ ထ / ဋေ ၁.၀၁ ထ
+၃.၀၁%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
၉၈၆.၆၀ ဋေ
၈၆၁.၈၀ ဋေ
ဋေ ၁.၀၁ ထ
ဋေ ၁.၀၄ ထ
Cost of goods sold
၂၆၇.၆၀ ဋေ
၂၄၉.၇၀ ဋေ
၂၇၅.၁၀ ဋေ
၂၇၈.၈၀ ဋေ
Cost of revenue
၂၆၇.၆၀ ဋေ
၂၄၉.၇၀ ဋေ
၂၇၅.၁၀ ဋေ
၂၇၈.၈၀ ဋေ
Research and development expenses
၂၁၄.၂၀ ဋေ
၁၇၁.၉၀ ဋေ
၁၈၆.၈၀ ဋေ
၂၁၁.၁၀ ဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁၉၅.၂၀ ဋေ
၁၆၀.၂၀ ဋေ
၁၇၄.၅၀ ဋေ
၁၆၈.၀၀ ဋေ
Operating expense
၄၁၇.၆၀ ဋေ
၃၂၀.၈၀ ဋေ
၃၇၂.၉၀ ဋေ
၃၈၆.၇၀ ဋေ
Total operating expenses
၆၈၅.၂၀ ဋေ
၅၇၀.၅၀ ဋေ
၆၄၈.၀၀ ဋေ
၆၆၅.၅၀ ဋေ
Operating income
၃၀၁.၄၀ ဋေ
၂၉၁.၃၀ ဋေ
၃၅၇.၄၀ ဋေ
၃၇၁.၀၀ ဋေ
Other non operating income
၁၄.၃၀ ကုဋေ
၁၉.၂၀ ကုဋေ
၁၄.၅၀ ကုဋေ
၁၂.၇၀ ကုဋေ
EBT including unusual items
၁၅၁.၄၀ ဋေ
၂၀၈.၄၀ ဋေ
၂၇၆.၈၀ ဋေ
၄၆၈.၆၀ ဋေ
EBT excluding unusual items
၂၅၀.၉၀ ဋေ
၂၃၇.၁၀ ဋေ
၃၀၅.၅၀ ဋေ
၃၁၈.၆၀ ဋေ
Income tax expense
၁၈.၁၀ ကုဋေ
၂၆.၅၀ ကုဋေ
၃၉.၃၀ ကုဋေ
၈၂.၂၀ ကုဋေ
Effective tax rate
၁၁.၉၆%
၁၂.၇၂%
၁၄.၂၀%
၁၇.၅၄%
Other operating expenses
၈.၂၀ ကုဋေ
-၁၁.၃၀ ကုဋေ
၁၁.၆၀ ကုဋေ
၇.၆၀ ကုဋေ
Net income
၁၃၃.၃၀ ဋေ
၁၈၁.၉၀ ဋေ
၂၃၇.၅၀ ဋေ
၃၈၆.၄၀ ဋေ
Net profit margin
၁၃.၅၁%
၂၁.၁၁%
၂၃.၆၂%
၃၇.၂၈%
Earnings per share
၅.၂၉
၅.၁၅
၆.၂၉
၆.၄၅
Interest and investment income
၄၀.၈၀ ကုဋေ
-
-
-
Interest expense
-၁၀၆.၁၀ ဋေ
-၆၅.၇၀ ကုဋေ
-၆၇.၃၀ ကုဋေ
-၆၅.၃၀ ကုဋေ
Net interest expenses
-၆၅.၃၀ ကုဋေ
-၆၅.၇၀ ကုဋေ
-၆၇.၃၀ ကုဋေ
-၆၅.၃၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၄၀၂.၂၀ ဋေ
၄၀၂.၉၀ ဋေ
၄၆၈.၆၀ ဋေ
၄၈၃.၂၀ ဋေ
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ